PCI to begin operations at newly expanded European site

International pharmaceutical outsourcing services provider, PCI Clinical Services, has received the green light to begin operations in its newly expanded European Clinical Services Centre of Excellence.

The new clinical storage and distribution facility is an expansion of the company’s site located in Bridgend, UK, and will begin operations this month (January). It provides 37,500 sq ft of additional warehouse and office space with scope for further expansion on adjacent land.

“The expansion of our site in Bridgend enables us to provide more world-class expertise and support to our clients to ensure timely delivery of life-saving medicines for patients around the world,” explained PCI’s managing director for European Clinical Services Fiona Withey. “As the demand for international trial support continues to increase, investments in our growth and expansion allow us to provide expertise and capacity to meet current and future client needs.”

“This is the latest in a series of significant investments by PCI in Bridgend, with a purpose-built and dedicated –40°C facility; as well as a broader Cold Chain capacity expansion that increased site storage by more than 400%; in addition to continued expansion of frozen storage at –80°C,” added PCI’s operations director Kevin Williams. “From refrigerated conditions down to cryogenic temperatures, the market is realizing medicines with very specific requirements for end-to-end controlled temperature logistics. We continue to invest in added capacity to meet those specific client needs.”

He continued: “These investments mirror PCI investments at other European and North American sites, supporting services for temperature controlled materials for clinical trials and its considerable business growth in this segment.”